NSAID Toxicity

Nonsteroidal anti-inflammatory drug toxicity in horses represents a significant and preventable cause of morbidity and mortality resulting from inappropriate use or overdosing of commonly prescribed medications including phenylbutazone, flunixin meglumine, and ketoprofen. These medications are among the most frequently administered drugs in equine practice, valued for their effective pain relief, fever reduction, and anti-inflammatory properties. However, their widespread use creates substantial risk for toxicity when proper dosing guidelines, treatment duration limits, or contraindications are not carefully observed. NSAID toxicity can affect multiple organ systems with the gastrointestinal tract and kidneys being most commonly and severely impacted.

The prevalence of NSAID toxicity in horses is difficult to quantify precisely because many cases go unrecognized or are attributed to other causes, but the condition is widely acknowledged as a common iatrogenic problem in equine medicine. Horses of all ages and breeds can be affected, though certain populations face elevated risk including dehydrated horses, those with pre-existing kidney disease, horses receiving multiple NSAIDs concurrently, and those treated for extended periods beyond recommended guidelines. Performance horses whose owners may be tempted to medicate heavily to maintain competition schedules face particular risk, as do horses with chronic painful conditions requiring ongoing pain management.

The impact of NSAID toxicity on equine health ranges from mild, reversible gastrointestinal irritation to life-threatening complications including right dorsal colitis, renal papillary necrosis, and protein-losing enteropathy. Right dorsal colitis represents the most characteristic manifestation of NSAID toxicity in horses, involving severe inflammation and ulceration of a specific segment of the large colon that can cause chronic diarrhea, weight loss, and hypoproteinemia. Oral ulceration, gastric ulcers, and small intestinal damage may also occur. Kidney damage from NSAID toxicity can result in acute kidney injury or progress to chronic renal insufficiency. The economic impact includes treatment costs, lost use of affected horses, and potential permanent reduction in athletic capability.

NSAID toxicity is generally treatable when recognized early and managed appropriately, though severe cases involving extensive colonic damage or significant renal impairment may have guarded to poor prognosis. Prevention through proper drug use remains the most effective strategy, as many cases of NSAID toxicity are entirely avoidable through adherence to established dosing guidelines and appropriate patient selection. Horse owners and equine professionals must understand the risks associated with these commonly used medications and recognize that their ready availability does not diminish their potential for serious harm when misused. Early recognition of signs suggesting NSAID toxicity and prompt veterinary intervention offer the best opportunity for successful treatment and recovery.

The primary cause of NSAID toxicity in horses is the administration of nonsteroidal anti-inflammatory drugs at doses exceeding recommended levels, for durations longer than recommended, or in patients with conditions that increase susceptibility to adverse effects. Phenylbutazone remains the most commonly implicated NSAID due to its widespread use and relatively narrow margin of safety in horses, though all NSAIDs including flunixin meglumine, ketoprofen, firocoxib, and meloxicam carry potential for toxicity. Overdosing may result from calculation errors, inappropriate scaling of doses for body weight, or intentional administration of higher doses in attempts to achieve greater pain relief. Extended treatment duration beyond the labeled recommendations of three to five days for most NSAIDs allows cumulative tissue damage to develop.

Concurrent administration of multiple NSAIDs represents a particularly dangerous practice that significantly increases toxicity risk. This practice, sometimes called stacking, may occur when horses receive different NSAIDs simultaneously or when one NSAID is started before a previously administered drug has been completely eliminated. The combined inhibition of protective prostaglandins from multiple agents dramatically increases the risk of gastrointestinal and renal damage. Competition horses may be at elevated risk if trainers attempt to maximize pain relief using multiple medications or if medication records are not carefully maintained across different caregivers.

Environmental and management factors that predispose horses to NSAID toxicity include conditions that compromise tissue perfusion and prostaglandin-dependent protective mechanisms. Dehydration significantly increases the risk of renal toxicity by reducing blood flow to the kidneys at a time when NSAID administration further compromises prostaglandin-mediated renal blood flow autoregulation. Horses with pre-existing gastrointestinal disease or stress may have compromised mucosal defenses making them more susceptible to NSAID-induced damage. Concurrent corticosteroid administration increases gastrointestinal toxicity risk. Poor nutrition, intestinal parasitism, and stress can all reduce the ability of the gastrointestinal tract to resist NSAID-mediated injury.

Risk factors for NSAID toxicity include age, hydration status, concurrent disease, and specific medication characteristics. Ponies appear more susceptible to phenylbutazone toxicity than full-sized horses, requiring lower weight-based doses. Foals and geriatric horses may have altered drug metabolism affecting their susceptibility. Horses with chronic kidney disease or reduced renal function face dramatically elevated risk of nephrotoxicity. Those with existing gastrointestinal pathology including gastric ulcers or inflammatory bowel disease may experience accelerated damage from NSAID administration. Fasting or reduced feed intake during illness may decrease the protective effects of food in the gastrointestinal tract.

The pathophysiology of NSAID toxicity relates directly to the mechanism of action of these drugs. NSAIDs inhibit cyclooxygenase enzymes responsible for prostaglandin synthesis, which is the basis for their therapeutic anti-inflammatory and analgesic effects. However, prostaglandins also serve critical protective functions in the gastrointestinal tract including maintaining mucosal blood flow, stimulating mucus production, and promoting epithelial cell turnover. In the kidneys, prostaglandins help maintain blood flow particularly during periods of reduced perfusion. NSAID inhibition of these protective prostaglandins allows acid-mediated damage to gastrointestinal mucosa and reduces renal perfusion, particularly in the medullary region. The right dorsal colon appears particularly susceptible to NSAID injury due to its blood supply characteristics and the local prostaglandin environment, resulting in the characteristic right dorsal colitis seen in chronic NSAID toxicity.

Early warning signs of NSAID toxicity in horses may be subtle and easily overlooked, particularly in horses already being treated for painful conditions that might mask or confuse the clinical picture. Initial gastrointestinal effects may manifest as decreased appetite or mild changes in manure consistency that owners might attribute to other causes or the primary condition being treated. Mild depression or lethargy beyond what would be expected from the underlying disease process should raise suspicion. Some horses develop oral ulceration early in toxicity, and careful examination of the lips, gums, and tongue may reveal eroded areas or increased sensitivity to palpation. Slight reductions in water intake may precede more obvious signs of illness and contribute to worsening of renal effects.

Common symptoms of established NSAID toxicity become more obvious as tissue damage progresses. Decreased appetite advancing to complete anorexia is frequently observed, with horses showing progressively less interest in feed over days to weeks. Diarrhea ranging from soft manure to watery feces develops as colonic inflammation and ulceration impair normal absorptive function. Weight loss becomes apparent as nutritional absorption decreases and protein is lost through the damaged intestinal wall. Ventral edema including swelling under the jaw, chest, and abdomen develops secondary to hypoproteinemia from protein-losing enteropathy. Horses may show colic signs including pawing, looking at the flanks, or restlessness due to abdominal discomfort from the inflamed bowel.

Behavioral changes in horses experiencing NSAID toxicity reflect both the direct effects of the condition and the general malaise that accompanies serious illness. Depression and reduced interaction with handlers and herdmates is common as horses feel increasingly unwell. Reluctance to move or exercise may be observed, though this can be difficult to distinguish from the effects of the primary painful condition for which NSAIDs were prescribed. Changes in social hierarchy may occur as affected horses become less able to maintain their position within herd dynamics. Some horses become irritable or sensitive to handling as abdominal discomfort worsens. Reduction in normal behaviors including grazing, mutual grooming, and play activity indicates declining wellbeing.

Physical signs of NSAID toxicity include several measurable abnormalities that help confirm the diagnosis. Oral ulceration visible as eroded or raw areas on the gums, tongue, or lips is particularly associated with phenylbutazone toxicity. Increased heart rate may reflect pain, dehydration, or developing systemic compromise. Reduced skin turgor and tacky mucous membranes indicate dehydration. Decreased gastrointestinal sounds on auscultation may accompany reduced motility, or sounds may be increased with hypermotile diarrhea. Edema may be palpable along the ventral abdomen, between the front legs, or under the jaw. Weight loss may be dramatic in horses with significant protein-losing enteropathy.

Symptom progression in NSAID toxicity typically follows a gradual pattern with worsening over days to weeks as continued drug administration or failure to recognize the problem allows tissue damage to accumulate. Early subtle changes in appetite and manure progress to obvious diarrhea and weight loss. Mild oral lesions may progress to extensive ulceration affecting feeding ability. Protein loss through the damaged gut leads to increasingly severe hypoproteinemia with progressive edema. Dehydration and reduced tissue perfusion may result in acute kidney injury superimposed on chronic NSAID-mediated renal damage. In severe cases, horses may develop laminitis as a complication of systemic inflammation and endotoxemia.

Emergency symptoms requiring immediate veterinary care include signs of severe colic that might indicate intestinal complications, significantly elevated heart rate suggesting cardiovascular compromise, extreme weakness or inability to rise, profuse watery diarrhea with rapid dehydration, or development of laminitis signs including reluctance to walk and increased digital pulses. Horses showing signs of shock including cold extremities, rapid weak pulse, and pale mucous membranes require emergency intervention. Sudden worsening after a period of apparent stability should prompt immediate veterinary evaluation. Any horse receiving NSAIDs that develops unexpected clinical deterioration should be assessed for potential drug toxicity.

Physical examination of horses suspected of NSAID toxicity includes thorough evaluation of the gastrointestinal tract, hydration status, and overall condition. Careful inspection of the oral cavity reveals ulceration characteristic of phenylbutazone toxicity. Abdominal auscultation assesses gut motility and may detect the hypermotile sounds of active diarrhea or decreased sounds suggesting ileus. Rectal examination allows palpation of the right dorsal colon for wall thickening characteristic of right dorsal colitis, though this finding may not always be appreciable. Assessment of hydration through skin turgor, mucous membrane moisture, and capillary refill time helps guide fluid therapy decisions. Evaluation of peripheral edema documents the extent of protein loss. Complete history including all medications administered, doses, duration of treatment, and any concurrent therapies is essential.

Diagnostic tests for NSAID toxicity provide objective evidence of organ damage and help guide treatment decisions. Complete blood count may show anemia of chronic disease or inflammatory changes. Serum biochemistry reveals hypoproteinemia with reduced albumin and total protein levels in horses with protein-losing enteropathy. Kidney function tests including blood urea nitrogen and creatinine may be elevated in horses with renal involvement. Electrolyte panels may show abnormalities related to diarrhea and altered intestinal absorption. Urinalysis may reveal evidence of kidney damage including protein or cellular casts. Fecal albumin or alpha-1 antitrypsin testing can confirm intestinal protein loss.

Advanced diagnostics help confirm the diagnosis and characterize the extent of damage. Abdominal ultrasound represents the most valuable diagnostic tool for right dorsal colitis, revealing characteristic thickening of the right dorsal colon wall that exceeds the normal four millimeter measurement and may reach ten millimeters or more in severe cases. Gastroscopy evaluates for concurrent gastric ulceration which commonly accompanies NSAID toxicity. Rectal mucosal biopsy may demonstrate inflammatory changes consistent with colitis. Kidney biopsy can confirm renal papillary necrosis in cases with significant nephrotoxicity though this is rarely performed. Abdominocentesis may show changes in peritoneal fluid indicating intestinal compromise.

Differential diagnosis for NSAID toxicity includes other causes of colitis, diarrhea, weight loss, and protein-losing enteropathy in horses. Inflammatory bowel disease including granulomatous enteritis and eosinophilic enterocolitis presents similarly but lacks the medication history. Salmonellosis and other infectious causes of colitis can cause acute diarrhea and systemic illness. Parasitism, particularly cyathostominosis, causes diarrhea and weight loss. Sand enteropathy in horses from sandy regions affects the right dorsal colon area. Neoplasia including lymphoma can cause protein-losing enteropathy. Clostridial colitis presents with acute severe diarrhea. Anterior enteritis causes small intestinal dysfunction with potential overlap in presentation. The key differentiating feature is the history of NSAID administration, which combined with characteristic ultrasound findings and appropriate clinical signs, establishes the diagnosis of NSAID toxicity.

Emergency and immediate treatment for NSAID toxicity begins with cessation of all NSAID administration, which is the essential first step regardless of other treatment measures. If the horse is dehydrated or showing signs of acute illness, intravenous fluid therapy should be initiated promptly to restore hydration, support kidney function, and improve tissue perfusion. Balanced polyionic crystalloid solutions are typically used, with rates adjusted based on the severity of dehydration and ongoing losses. Colloid support using plasma transfusion may be necessary in severely hypoproteinemic horses to maintain oncotic pressure and reduce edema while the intestinal tract heals. Horses with significant colic signs require appropriate pain management using drugs other than NSAIDs, such as butorphanol for analgesia.

Medical management of NSAID toxicity focuses on protecting damaged tissues and promoting healing. Sucralfate administration provides physical protection to ulcerated surfaces in the gastrointestinal tract by binding to exposed tissue and creating a barrier against further acid damage. Proton pump inhibitors such as omeprazole or esomeprazole reduce gastric acid secretion to protect against gastric ulceration and reduce acid load reaching the damaged colon. Misoprostol, a synthetic prostaglandin analog, helps replace the protective prostaglandins depleted by NSAID administration and promotes mucosal healing. Antimicrobial therapy may be indicated if secondary bacterial complications are suspected or if mucosal barrier compromise creates risk of bacterial translocation.

Nutritional support is a critical component of treatment for NSAID toxicity, particularly right dorsal colitis. Dietary modification typically involves eliminating long-stem hay and concentrates in favor of easily digestible feeds that minimize mechanical irritation of the damaged colon. Complete pelleted feeds or senior feeds soaked to a mash consistency provide nutrition while reducing fiber content. Fresh grass grazing when available provides excellent nutrition with minimal irritation. Some horses benefit from psyllium supplementation to provide soluble fiber that supports intestinal health without abrasive effects. Corn oil or other vegetable oils may be added to increase caloric density and provide essential fatty acids. Parenteral nutrition may be necessary in horses unable to tolerate enteral feeding.

Supportive care for horses with NSAID toxicity addresses the complications and secondary effects of the condition. Management of peripheral edema through leg wrapping, controlled exercise, and diuretic therapy when appropriate helps maintain comfort. Prevention of laminitis in horses with significant systemic inflammation requires careful attention to hoof care and potentially prophylactic cryotherapy. Electrolyte supplementation addresses losses from diarrhea and supports normal physiological function. Treatment of secondary infections with appropriate antimicrobials may be necessary. Monitoring and management of coagulation status is important in horses with significant protein loss.

Long-term management of NSAID toxicity requires sustained commitment to dietary modification and continued medical therapy. Horses recovering from right dorsal colitis may require months of restricted diet before gradually reintroducing normal feedstuffs. Continued administration of sucralfate and acid suppression medications protects healing tissues. Slow dietary transitions over weeks to months allow assessment of individual tolerance as fiber content is gradually increased. Regular monitoring of protein levels confirms improving intestinal function. Follow-up ultrasound examinations document resolution of colonic wall thickening.

Treatment decisions for NSAID toxicity must consider the severity of organ damage, the horse's intended use, and economic factors. Mild cases with early recognition and appropriate management carry good prognosis for complete recovery. Moderate cases may recover with extended treatment but may have permanent reduction in intestinal reserve function. Severe cases with extensive colonic damage, profound hypoproteinemia, or significant renal impairment carry guarded prognosis and may require prolonged intensive care with uncertain outcome. Euthanasia may be appropriate for horses with severe, unresponsive disease or those facing quality of life limitations they cannot overcome. Open communication with owners about prognosis helps guide realistic treatment planning.

Recovery timeline for horses with NSAID toxicity varies substantially based on the severity of tissue damage, the specific organs affected, and the promptness of treatment initiation. Mild cases involving primarily gastric ulceration with minimal colonic involvement may show significant improvement within two to four weeks of NSAID discontinuation and appropriate medical management. Moderate right dorsal colitis typically requires two to four months of treatment and dietary modification before substantial recovery occurs. Severe cases with extensive colonic damage and profound protein loss may require six months or longer of intensive management, and some horses never fully recover normal intestinal function despite optimal treatment.

Post-treatment care and monitoring for horses recovering from NSAID toxicity requires consistent attention to diet, medication administration, and clinical status. Serial serum protein measurements track improvement in intestinal function and guide decisions about dietary advancement. Periodic ultrasound examinations monitor resolution of right dorsal colon wall thickening, with measurements returning toward normal four millimeters as healing progresses. Body weight should be recorded regularly to confirm nutritional adequacy and recovery of normal body condition. Manure consistency provides daily indication of intestinal function. Appetite and attitude are monitored as indicators of overall wellbeing. Kidney function tests should be rechecked in horses that showed evidence of nephrotoxicity.

Prognosis factors for NSAID toxicity include the severity of initial presentation, the extent of colonic wall thickening on ultrasound, the degree of hypoproteinemia, and the presence or absence of renal involvement. Horses with mild to moderate right dorsal colitis and serum albumin levels above two grams per deciliter generally carry favorable prognosis for return to normal function. Severe hypoproteinemia with albumin levels below 1.5 grams per deciliter suggests extensive intestinal damage and carries more guarded prognosis. Concurrent renal damage complicates recovery and may result in permanent reduction in kidney function. Horses that respond quickly to treatment with improving protein levels within the first few weeks carry better long-term prognosis than those showing delayed or minimal response.

Long-term soundness outlook for horses recovering from NSAID toxicity depends primarily on the completeness of gastrointestinal healing. Many horses that achieve full recovery can return to their previous level of work and performance without lasting limitations. However, some horses retain permanent reduction in intestinal reserve function that may manifest as sensitivity to dietary changes, reduced ability to maintain weight on normal rations, or intermittent episodes of loose manure or mild colic. Horses that required prolonged recovery periods may never fully regain normal intestinal function and may require permanent dietary modification. Future use of NSAIDs in horses that have experienced toxicity requires extreme caution if not complete avoidance, as these horses may have heightened susceptibility to repeated injury.

Management practices to prevent NSAID toxicity center on appropriate drug use following established guidelines and veterinary oversight. All NSAID administration should be based on accurate body weight with doses calculated precisely rather than estimated. Treatment duration should not exceed label recommendations without specific veterinary guidance and reassessment. The practice of stacking multiple NSAIDs should be completely avoided, with adequate washout periods between different medications. Written treatment protocols should document all medications administered, doses, and timing to prevent inadvertent overdosing when multiple caregivers are involved. Regular veterinary consultation ensures appropriate drug selection and dosing for individual patients.

Patient selection and risk factor management significantly reduce NSAID toxicity risk. Hydration status should be optimized before and during NSAID administration, with fluid therapy provided to horses that are or may become dehydrated. Horses with pre-existing kidney disease or reduced renal function should receive NSAIDs only with extreme caution if at all. Concurrent corticosteroid administration should be avoided when possible, and when necessary, the combination should be used at lowest effective doses for shortest possible duration. Horses with existing gastrointestinal disease may benefit from gastroprotective medications when NSAIDs are necessary. Ponies should receive weight-appropriate doses lower than those used in full-sized horses.

Monitoring during NSAID therapy allows early detection of developing problems before serious toxicity occurs. Appetite and manure consistency should be assessed daily in horses receiving NSAIDs. Any reduction in appetite, change in manure quality, or development of oral ulceration should prompt immediate drug discontinuation and veterinary evaluation. Periodic blood work including kidney function tests and protein levels may be valuable in horses requiring extended treatment. Clinical examination before and during treatment identifies developing problems early.

Education and awareness about NSAID risks is essential for all individuals involved in horse care and medication administration. Owners, trainers, and barn staff should understand that NSAIDs are potent medications with real potential for serious harm despite their routine use. The temptation to increase doses beyond recommended levels in attempts to improve pain control should be recognized and resisted. Understanding that more medication does not necessarily produce better results and may cause serious harm helps prevent well-intentioned overdosing. Knowledge of early warning signs of NSAID toxicity enables prompt recognition and intervention.

Alternative approaches to pain management may allow reduced NSAID use in some horses, decreasing toxicity risk. Physical therapy, controlled exercise, and rehabilitation protocols can help manage musculoskeletal pain. Acupuncture, chiropractic care, and other complementary therapies may provide pain relief without NSAID risks in appropriate patients. Joint injections and other targeted treatments can address local pain sources. Nutraceuticals including glucosamine and omega-3 fatty acids may provide modest anti-inflammatory effects. When NSAIDs are necessary, using the lowest effective dose for the shortest necessary duration minimizes risk while achieving therapeutic goals.

Daily management adjustments for horses recovering from or living with chronic effects of NSAID toxicity focus on supporting compromised intestinal function while maintaining quality of life. Feeding schedules should provide multiple small meals throughout the day rather than large infrequent feedings, reducing the digestive workload at any one time. Consistent feeding times support normal gastrointestinal rhythm and function. Careful observation of manure quality and appetite at each feeding provides early warning of any deterioration. Access to fresh, clean water should be maximized to maintain hydration. Stress should be minimized through consistent routines and stable social environments. Medications including sucralfate should be administered consistently on the prescribed schedule.

Housing and turnout considerations for horses with NSAID toxicity-related intestinal compromise include ensuring access to appropriate forage while avoiding dietary indiscretions. Pasture turnout provides the opportunity for continuous grazing of fresh grass, which is generally well-tolerated by horses with right dorsal colitis. Pastures should be evaluated for toxic plants, sand content, and other potential problems. If hay feeding is necessary, soft, easily digestible varieties are preferred over coarse stemmy hay. Hay nets with small openings can slow consumption and promote more thorough chewing. Horses should be separated from herdmates during feeding to prevent consumption of inappropriate feeds. Shelter from weather extremes helps minimize physiological stress.

Exercise modifications for horses affected by NSAID toxicity depend on their overall condition and stage of recovery. During active treatment and early recovery, light exercise promotes gastrointestinal motility and overall wellbeing without excessive stress. Walking in hand or turnout in small paddocks provides appropriate activity for recovering horses. Gradual return to work can proceed as condition improves and protein levels normalize. Horses should not return to intense exercise until gastrointestinal healing is confirmed through normalized blood work and ultrasound findings. Future exercise management should include careful attention to pain management strategies that minimize or eliminate NSAID requirements.

Monitoring and ongoing care requirements for horses with NSAID toxicity history include regular veterinary assessments and owner vigilance. Periodic blood work monitors protein levels, kidney function, and overall health status. Weight should be recorded monthly or more frequently to detect early losses that might indicate recurring problems. Any changes in appetite, attitude, manure quality, or exercise tolerance should prompt veterinary consultation. Documentation of the toxicity episode including medications involved, doses, and clinical course should be maintained for future reference. All future caregivers should be informed of the horse's history and susceptibility.

Quality of life and use considerations for horses that have experienced NSAID toxicity require honest assessment of their capabilities and limitations. Many horses recover sufficiently to return to their previous activities with appropriate management. Some horses retain permanent limitations that may affect their suitability for certain activities or require ongoing dietary modifications. Future pain management needs must be addressed without reliance on NSAIDs, which may require exploring alternative therapies and modifying expectations about performance. The emotional bond between horse and owner should be considered alongside practical limitations when making decisions about future use. Horses that cannot achieve acceptable quality of life despite appropriate management may require humane retirement or euthanasia decisions.

Ponies are recognized as being more susceptible to NSAID toxicity than full-sized horses, requiring lower weight-based doses and closer monitoring during treatment. This increased susceptibility appears to relate to differences in drug metabolism and possibly increased sensitivity of gastrointestinal tissues to prostaglandin inhibition. All pony breeds including Welsh, Shetland, Connemara, and others should receive conservative NSAID dosing with careful attention to accurate weight estimation. Miniature horses share this increased susceptibility and require similarly cautious dosing approaches. Owners and veterinarians working with ponies must be particularly vigilant about following strict dosing guidelines and monitoring for early signs of toxicity.

Use and discipline considerations affect NSAID toxicity risk primarily through the intensity and frequency of medication use rather than the activities themselves. Performance horses in demanding disciplines including racing, eventing, show jumping, and reining may receive NSAIDs more frequently and at higher doses than pleasure horses, increasing their cumulative exposure and toxicity risk. Horses in regular competition face pressure to maintain performance schedules that may encourage heavy medication use. Racehorses historically have received intensive NSAID therapy that has been associated with significant toxicity rates. Horses with chronic conditions requiring ongoing pain management face elevated long-term exposure risk.

Genetic testing is not applicable for NSAID toxicity susceptibility, as this condition results from medication use rather than inherited characteristics. However, understanding individual variation in drug metabolism and sensitivity can help guide treatment decisions. Horses that have previously experienced NSAID-related problems should be considered at elevated risk for future toxicity and treated with extreme caution if NSAIDs are necessary. Documentation of adverse reactions helps guide future treatment decisions. Breeding considerations should include awareness that NSAID toxicity is a management-related condition preventable through appropriate medication practices rather than selective breeding.

Commonly co-occurring conditions with NSAID toxicity include gastric ulceration, which frequently accompanies colonic damage from NSAID administration. Equine gastric ulcer syndrome may precede NSAID use and worsen with treatment, or may develop as a direct result of prostaglandin inhibition in the stomach. Oral ulceration particularly associated with phenylbutazone use may occur alongside or independently of gastrointestinal tract damage. Acute kidney injury develops when NSAID-mediated inhibition of prostaglandin-dependent renal blood flow autoregulation combines with dehydration or other factors compromising renal perfusion. Laminitis may develop as a complication of severe systemic inflammation and endotoxemia in horses with significant intestinal barrier compromise.

Conditions with similar symptoms to NSAID toxicity require differentiation through history and diagnostic evaluation. Inflammatory bowel disease including granulomatous enteritis and lymphocytic-plasmacytic enterocolitis presents with chronic diarrhea, weight loss, and hypoproteinemia similar to right dorsal colitis. Salmonellosis causes acute colitis with diarrhea and systemic illness. Cyathostominosis produces weight loss and diarrhea from encysted small strongyle emergence. Sand enteropathy affecting the right dorsal colon area creates similar clinical and ultrasonographic findings. Neoplasia including intestinal lymphoma causes protein-losing enteropathy. Hepatic disease can produce hypoproteinemia through reduced albumin synthesis. The medication history and characteristic pattern of ultrasound findings help establish NSAID toxicity as the diagnosis.

Potential complications of NSAID toxicity extend beyond the immediate gastrointestinal effects. Chronic kidney disease may develop following acute renal injury, particularly if early signs are not recognized and NSAID administration continues. Severe protein loss can lead to coagulation abnormalities from depletion of clotting factors. Secondary infections may occur when mucosal barrier compromise allows bacterial translocation. Electrolyte disturbances from chronic diarrhea can affect cardiac and muscle function. Thrombophlebitis may complicate intravenous catheterization during treatment. Long-term nutritional deficiencies may develop in horses with permanent intestinal damage. Laminitis occurring as a complication may cause lasting hoof damage affecting future soundness. The psychological effects of prolonged illness and treatment should not be overlooked in affected horses.